Lect. PhD ALİ OĞUL

Publication Network

Articles 16

1. Brigatinib-associated autoimmune hepatitis: A case report

Buyuksimsek M., Ogul A., Yetisir A. E., Duman B. B., Tohumcuoglu M., Cil T., et al.

Journal of Oncology Pharmacy Practice , vol.32, no.4, pp.754-756, 2026 (SCI-Expanded, Scopus)

2. Association of systemic inflammatory markers with prognosis in erlotinib-treated EGFR-mutant non-small cell lung cancer

Yetişir A. E., PAYDAŞ S., Büyükşimşek M., Oğul A., Kolsuz İ., Kıdı M. M.

Journal of Cancer Research and Therapeutics , vol.20, no.1, pp.285-288, 2024 (SCI-Expanded, Scopus)

3. Advanced Biliary Tract Cancer Treated with Gemcitabine plus Cisplatin (GEMCIS) and Novel Inflammatory Markers

Ogul A., Kidi M. M., Buyuksimsek M.

JOURNAL OF GASTROINTESTINAL CANCER , vol.52, no.1, pp.294-299, 2021 (ESCI, Scopus) Sustainable Development

4. The Effect of Inflammatory Markers on Survival in Advanced Biliary Tract Carcinoma Treated with Gemcitabine/Oxaliplatin Regimen

Buyuksimsek M., Kidi M. M., Ogul A., Mirili C., PAYDAŞ S.

JOURNAL OF GASTROINTESTINAL CANCER , vol.52, no.1, pp.249-255, 2021 (ESCI, Scopus)

5. Prognostic significance of EGFR, MUC1 and PD-L1 expressions in cases with triple negative breast cancer

MİRİLİ C., PAYDAŞ S., BAĞIR KILIÇ E., SEYDAOĞLU G., OĞUL A., GÖKÇAY S., et al.

JOURNAL OF BUON , vol.25, no.1, pp.159-167, 2020 (SCI-Expanded, Scopus) Sustainable Development

6. Dynamic prognostic nutritional index could be a novel predictor of survival in lung cancer patients treated with nivolumab

MİRİLİ C., PAYDAŞ S., OĞUL A., GÖKÇAY S., BÜYÜKŞİMŞEK M., YETİŞİR A. E., et al.

ANNALS OF CLINICAL AND ANALYTICAL MEDICINE , vol.11, pp.1-6, 2020 (ESCI) Sustainable Development

7. Prognostic significance of neutrophil/lymphocyte ratio (NLR) and correlation with PET-CT metabolic parameters in small cell lung cancer (SCLC)

Mirili C., Güney İ. B., Paydaş S., Seydaoğlu G., Kapukaya T. K., Oğul A., et al.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.24, no.2, pp.168-178, 2019 (SCI-Expanded, Scopus)

8. Atypical Radiologic Image Characterized by Cavitary Lung Lesions in a Case of Hodgkin Lymphoma

BÜYÜKŞİMŞEK M., PAYDAŞ S., GÜMÜRDÜLÜ D., MİRİLİ C., OĞUL A., YETİŞİR A. E., et al.

TURKISH JOURNAL OF HEMATOLOGY , vol.36, no.1, pp.60-61, 2019 (SCI-Expanded, Scopus, TRDizin)

9. Prognostic significance of dynamic inflammatory indexes in cases renal cell cancer treated by tyrosine kinase inhibitor (TKI)

MIRILI C., PAYDAŞ S., YILMAZ A., OGUL A., BUYUKSIMSEK M., YETISIR A. E., et al.

Acta Oncologica Turcica , vol.52, no.3, pp.372-378, 2019 (TRDizin)

10. Assessment of potential predictive value o f peripheral blood inflammatory indexes in 26 cases with soft tissue sarcoma treated by pazopanib: a retrospective study

Mirili C., Payday S., Güney İ. B., Oğul A., Gökçay S., Büyükşimşek M., et al.

CANCER MANAGEMENT AND RESEARCH , vol.11, pp.3445-3453, 2019 (SCI-Expanded, Scopus)

11. EGFR, MUC-1 and PD-L1 expressions in cases with triple negative breast cancer (TNBC).

Paydas S., Mirili C., Bagir E., Seydaoglu G., Ogul A., Buyuksimsek M., et al.

JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15, 2018 (SCI-Expanded, Scopus) Sustainable Development

12. Myeloid Neoplasia and Lymphoblastic Lymphoma with Eosinophilia After Radioactive Iodine: A Case Report.

Büyükşimşek M., PAYDAS S., Oğul A., Bağır E., Ergin M.

Balkan medical journal , vol.35, pp.199-202, 2018 (SCI-Expanded, Scopus, TRDizin)

13. G-CSF related hemophagocytosıs in a case with lymhphoma

PAYDAŞ S., YETİŞİR E., MİRİLİ C., İSMAYİLOV E., BÜYÜKŞİMŞEK M., OĞUL A., et al.

Clinical Research and Trials , vol.4, no.1, pp.1-2, 2018 (Peer-Reviewed Journal)

14. Pulmonary MALT lymphoma with underlying interstitial lung disease: A case report and rewiev of the literature

mirili c., PAYDAŞ S., oğul a., gökçay s., BÜYÜKŞİMŞEK M., YETİŞİR e., et al.

Journal of Oncological Sciences , vol.4, pp.56-59, 2018 (TRDizin)

15. The Importance of Parameters: MPV, MPV/Thrombocyte Ratio and Neutrophil/Lymphocyte Ratio in Sorafenib Treatment Response of Patients with Hepatocellular Cancer

OĞUL A., ŞAHİN B., KUŞCU F., Taktakoglu O., YETİŞİR A. E., BÜYÜKŞİMŞEK M., et al.

JOURNAL OF GASTROINTESTINAL CANCER , vol.48, no.3, pp.286-287, 2017 (ESCI, Scopus) Sustainable Development

16. Brentuximab vedotin use in a jaundiced case with resistant Hodgkin lymphoma

PAYDAŞ S., OĞUL A., Irili C., GÖKÇAY S.

ANNALS OF HEMATOLOGY , vol.95, no.1, pp.145-146, 2016 (SCI-Expanded, Scopus)

Papers Presented at Peer-Reviewed Scientific Conferences 3

1. EGFR, MUC-1 and PD-L1 expressions in cases with triple negative breast cancer (TNBC)

MİRİLİ C., PAYDAŞ S., BAĞIR KILIÇ E., SEYDAOĞLU G., OĞUL A., BÜYÜKŞİMŞEK M., et al.

ASCO 2018, Chicago, United States Of America, 1 - 05 June 2018, (Summary Text) Sustainable Development

2. KÜÇÜK HÜCRELİ AKCİĞER KANSERİNDE (KHAK) NÖTROFİL LENFOSİT ORANI (NLO) İLE PET-CT’DE SAPTANAN METABOLİK PARAMETRELERİNİN (PET-CT MP) PROGNOSTİK ÖNEMİ VE NLO İLE PET-CT MP İLİŞKİSİ

MİRİLİ C., PAYDAŞ S., GÜNEY İ. B., SEYDAOĞLU G., KAPUKAYA T. K., OĞUL A., et al.

7.Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 21 - 25 March 2018, (Summary Text) Sustainable Development

3. AİLEVİ AKDENİZ ATEŞİ SEMİNOMDA PREDİSPOZAN BİR FAKTÖR MÜDÜR ?

OĞUL A.

6. TÜRK TIBBİ ONKOLOJİ KONGRESİ, Antalya, Turkey, 23 - 27 March 2016, pp.1, (Full Text)

Metrics

Publication

Publication (WoS)

Publication (Scopus)

Citation (WoS)

H-Index (WoS)

Citation (Scopus)

H-Index (Scopus)

Citation (Scholar)

H-Index (Scholar)

Project

Open Access

UN Sustainable Development Goals

Publications & Works